These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8375429)

  • 1. Progress note on Japanese multicenter bromocriptine monotherapy.
    Kuno S
    Eur Neurol; 1993; 33 Suppl 1():3-5. PubMed ID: 8375429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment.
    Nakanishi T; Kanazawa I; Iwata M; Goto I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1992; 32 Suppl 1():23-9. PubMed ID: 1425818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.
    Yanagisawa N; Kanazawa I; Goto I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Ogawa N
    Eur Neurol; 1994; 34 Suppl 3():29-35. PubMed ID: 7821333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.
    Ogawa N; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Yanagisawa N
    Eur Neurol; 1997; 38 Suppl 2():37-49. PubMed ID: 9387802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report.
    Nakanishi T; Iwata M; Goto I; Kanazawa I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1992; 32 Suppl 1():9-22. PubMed ID: 1425821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report.
    Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1991; 31 Suppl 1():3-16. PubMed ID: 1906808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.
    Przuntek H; Welzel D; Schwarzmann D; Letzel H; Kraus PH
    Eur Neurol; 1992; 32 Suppl 1():36-45. PubMed ID: 1425819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
    Kowa H; Kanazawa I; Goto I; Kuno S; Mizuno Y; Ogawa N; Tashiro K; Yanagisawa N
    Eur Neurol; 1997; 38 Suppl 1():23-8. PubMed ID: 9276197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
    Tashiro K; Goto I; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Ogawa N; Yanagisawa N
    Eur Neurol; 1996; 36 Suppl 1():32-7. PubMed ID: 8791019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
    Montastruc JL; Rascol O; Senard JM; Rascol A
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1034-8. PubMed ID: 8089666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    Nakanishi T; Iwata M; Goto I; Kanazawa I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1989; 29 Suppl 1():3-8. PubMed ID: 2714305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    Nakanishi T; Kanazawa I; Goto I; Iwata M; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1990; 30 Suppl 1():3-8. PubMed ID: 2178938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
    Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1988; 28 Suppl 1():3-8. PubMed ID: 3378560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of Parkinson's disease. An overview.
    Mizuno Y
    Eur Neurol; 1992; 32 Suppl 1():3-8. PubMed ID: 1358614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine combined with levodopa in Parkinson's disease.
    Gauthier G; Martins da Silva A
    Eur Neurol; 1982; 21(4):217-26. PubMed ID: 7117308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
    Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL; Rascol O; Rascol A
    Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.
    Bouchard S
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):460-5. PubMed ID: 3676921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN; Meerwaldt JD
    Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.